Zydus Cadila Covid vaccine close to getting approved in India, says MD Sharvil Patel
In an exclusive interview with India Today TV, Managing Director of Zydus Cadila Dr Sharvil Patel said the company s Covid vaccine candidate ZyCoV-D against the Covid-19 infection is very close to getting approved in India. They are likely to apply for emergency use authorisation this month.
advertisement
UPDATED: May 8, 2021 08:38 IST
Zydus Cadila Covid vaccine is close to getting approved in India, the company MD said (PTI photo)
Ahmedabad-based pharmaceutical company Zydus Cadila is likely to submit the application for emergency use authorisation of its Covid-19 vaccine candidate ZyCoV-D in India this month. The company is confident that the vaccine will be approved in May itself. The company plants to produce one crore doses of its painless Covid-19 vaccine per month.
Bengaluru facing shortage of Remdesivir, other Covid-related drugs; govt sets up war room
Bengaluru facing shortage of Remdesivir, other Covid-related drugs; govt sets up war room
Pharmacies in Bengaluru are facing a shortage of Remdesivir and other Covid-related drugs due to a sudden spike in Covid-19 cases in the city.
advertisement
UPDATED: April 21, 2021 21:08 IST
Pharmacies in Bengaluru say the demand for Remdesivir started rising in the past 10 days as Covid-19 cases surged in the city. (Photo: Reuters)
With Covid-19 cases rising sharply in Bengaluru, the city is now facing an acute shortage of Remdesivir, a drug that is being used in emergency to treat critical Covid-19 patients who are hospitalised.